Lab / Saudi Arabia's first CAP-accredited genomics and precision medicine laboratory
Novo Genomics
Novo Genomics is Saudi Arabia's first CAP-accredited genomics laboratory, headquartered in Riyadh and focused on localizing next-generation sequencing, multi-omics, and pharmacogenomics to support Vision 2030 precision medicine goals. The lab offers whole genome and whole exome sequencing, targeted gene panels, molecular diagnostics, genetic counseling, and non-invasive prenatal testing. It partnered with PGxAI to deploy AI-enabled pharmacogenomics across the Kingdom; CAP re-accreditation confirmed in 2025.
Key people
- Dr. Budoor Almansour (Co-Founder and Chief Operating Officer)